超音波検査技術

ISSN: 1881-4506
一般社団法人日本超音波検査学会
〒162-0801 東京都新宿区山吹町358-5
Japanese Journal of Medical Ultrasound Technology 45(5): 483-490 (2020)
doi:10.11272/jss.310

症例報告Case Report

経胸壁心臓超音波が診断および治療効果判定に有用であった大動脈弁位生体弁血栓弁の1例Leaflet Thrombosis in Bioprosthetic Aortic Valves Detected by Transthoracic Echocardiography and Hyper-coagulation Activated by Inflammatory Reaction: A Case Report

1静岡県立病院機構静岡県立総合病院検査部検査技術・臨床工学室Department of Clinical Laboratory Medicine, Shizuoka Prefectural Hospital Organization, Shizuoka General Hospital

2静岡県立病院機構静岡県立総合病院循環器内科Department of Cardiovascular Medicine, Shizuoka General Hospital, Shizuoka Prefectural Hospital Organization

3静岡県立病院機構静岡県立総合病院臨床研究センターClinical Research Center, Shizuoka General Hospital, Shizuoka Prefectural Hospital Organization

受付日:2019年12月23日Received: December 23, 2019
受理日:2020年7月22日Accepted: July 22, 2020
発行日:2020年10月1日Published: October 1, 2020
HTMLPDFEPUB3

症例:大動脈弁,僧帽弁置換術後の70代男性.主訴は発熱と労作時息切れ.当院受診の血液検査で軽度の炎症反応上昇と心不全兆候を認め入院加療となった.入院時経胸壁心臓超音波検査(TTE)では,大動脈弁位生体弁の弁葉の一部に可動制限,肥厚と輝度上昇を認めた.経弁・弁周囲逆流所見は無く,可動性のある付着物はみられなかった.大動脈弁位生体弁最大通過血流速度(Vmax)は2.7 m/s, 平均圧較差(mPG)15 mmHg, 術後6か月を基準としたmPGの変化(ΔmPG)+6 mmHgであった.僧帽弁位生体弁には特記する所見はなかった.血液培養は陰性であったため,大動脈弁位生体弁への血栓付着の可能性が疑われ,抗凝固薬が開始となった.

経過:炎症のFocusは不明であったが,経験に基づき抗生剤と心不全治療を強化し抗凝固薬の導入を行い全身状態は改善し退院となった.退院後のTTEでは弁葉の肥厚は消失,可動制限はみられず,Vmaxは2.2 m/s, mPG 9 mmHg, ΔmPG 0 mmHgであった.

考察:術後中期以降の生体弁置換患者への抗凝固療法の必要性は今後議論が必要であるが,心不全兆候や炎症を伴う場合は積極的なTTE検査や他モダリティーでの精査によって血栓塞栓症を予防できると考える.本症例では生体弁の弁葉が明瞭に描出でき,早期の治療介入と経時的な形態変化の観察を通してTTEが治療に貢献したと考えられた.

We report a case of a 70-year-old male with leaflet thrombosis in a bioprosthetic aortic valve. The patient had a fever, symptoms and signs of heart failure, and was hospitalized for treatment. We suspected infective endocarditis (IE) and performed transthoracic echocardiography (TTE), but no evidence of IE was found. However, the right coronary cusp of the bioprosthetic valve showed dysfunction because it did not move flexibly with thrombosis. The aortic valve mean gradient (mPG) was 15 mmHg, the 6-month postoperative variation in mPG (ΔmPG) showed an increase of 6 mmHg, and the peak velocity (Vmax) was 2.7 m/s by TTE. A blood culture result was negative. We started anticoagulation therapy with warfarin, and subsequent TTE did not show any signs of dysfunction of the bioprosthetic valve (mPG: 9 mmHg, ΔmPG: 0 mmHg, Vmax: 2.2 m/s). In general, computed tomography is useful for evaluation of thrombotic valves, but this case illustrated the value of TTE for diagnosis and follow-up. Previous reports have also observed that inflammation can activate the coagulation process. It is possible that a crack or scratch on a bioprosthetic valve in patients with high C-reactive protein levels could cause thrombotic valve dysfunction. When there is a positive inflammatory reaction in a patient with a bioprosthetic valve, we should generally suspect IE, but it is essential to carefully observe the changes in the leaflets if thrombus adhesion is suspected.

Key words: transthoracic echocardiography; bioprosthetic valves; thrombotic valves

This page was created on 2020-08-13T09:58:27.049+09:00
This page was last modified on 2020-09-29T16:38:22.000+09:00


このサイトは(株)国際文献社によって運用されています。